Tower Hall Funabori4-1-1 FunaboriEdogawa-kuTokyo134-0091 JapanOct 27-28 2011Come visit NextDocs in booth 20The 8th DIA Japan Annual Meeting will provide the opportunity to learn new trends of global development and how to adapt to these trends in Japan. One of the topics is biomarkers. Although much prior discussion about the use of biomarkers in drug development has focused on surrogate endpoints for efficacy, most uses of new biomarkers are expected to involve the prediction of drug effects or disease progression. Both regulatory authorities and industry are becoming interested in the utilization of biomarkers to enhance not only regulatory decision making but also sponsors’ decisions at the early stages of development.
For more information, visit
http://www.diahome.org/DIAHome/Education/FindEducationalOffering.aspx?productID=25848&eventType=MeetingSee you at the show!